NOV News
NOV Inc.
$20.51
+$0.32(+1.58%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
1.56M
52W Range
$12.64 - $21.93
Target Price
--
NOV news: the latest NOV Inc. headlines, press releases and market updates, newest first.
Latest NOV News
- Novartis AG (NOVN) Receives a Hold from JefferiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 27, 2026
- Novo Nordisk Details Progress in DKK 15 Billion Share Buyback ProgrammeTipRanks Auto-Generated Newsdesk · Oct 26, 2026
- UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Novartis AG (NOVN) Gets a Hold from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Novatti Options Lapse Clarifies Future Capital StructureTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
- Novatti Seeks ASX Quotation for Nearly 6 Million New SharesTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
- Big Pharma’s Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)Newswire TipRanks · Oct 21, 2026
- Novartis AG (NOVN) Gets a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
- UBS Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- UBS Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- NOV (NOV) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Novo Nordisk Expands 2026 Share Buyback, Lifting Treasury Stake to 1.2%TipRanks Auto-Generated Newsdesk · Oct 19, 2026
- Novo Nordisk Details Progress in DKK 15 Billion Share Buyback ProgrammeTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Barclays Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
- Restart Life Advances Licensed Health Brands Toward Commercial LaunchTipRanks Canadian Auto-Generated Newsdesk · Oct 8, 2026
- Deutsche Bank Keeps Their Sell Rating on Novo Nordisk (0QIU)TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
- Analysts Conflicted on These Technology Names: AST SpaceMobile (ASTS) and Novanta (NOVT)TipRanks Newsroom · Oct 5, 2026
- J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)TipRanks Auto-Generated Intelligence Newsdesk · Oct 5, 2026
- Novina PozyczkiHipoteczne.eu Expands Share Buyback to 1.22% of CapitalTipRanks Poland Auto-Generated Newsdesk · Oct 2, 2026
- Goldman Sachs Remains a Sell on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NOV | $20.51 | +1.6% | 1.56M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |